Eagle Pharmaceuticals Inc. (EGRX) was a big mover last session, as the company saw its shares rise by roughly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now 23% in the past one-month time frame.
This medical products company has seen one positive estimate revision over the past 30 days and its Zacks Consensus Estimate has moved higher over the same time frame, suggesting that more solid trading could be ahead for Eagle Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.
Eagle Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Some better-ranked stocks in the same sector include Advaxis, Inc. (ADXS), Cytosorbents Corporation (CTSO) and FluoroPharma Medical, Inc. (FPMI). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
EAGLE PHARMACEUTICALS INC (EGRX): Free Stock Analysis Report
ADVAXIS INC (ADXS): Free Stock Analysis Report
CYTOSORBENTS CORP (CTSO): Free Stock Analysis Report
FLUOROPHARMA MEDICAL INC (FPMI): Free Stock Analysis Report
Zacks Investment Research